Company Filing History:
Years Active: 1999
Title: Jin Il Choi: Innovator in Neuropharmacology
Introduction
Jin Il Choi is a notable inventor based in Taejon-si, South Korea. He has made significant contributions to the field of neuropharmacology, particularly through his innovative research on NMDA receptor antagonists. His work aims to address critical health issues related to neuro-degenerative disorders.
Latest Patents
Jin Il Choi holds 1 patent for his invention titled "Quinolinic sulfide derivatives acting as NMDA receptor antagonists." This patent describes a class of quinolinic sulfide derivatives that serve as potent and specific antagonists at the strychnine insensitive glycine binding site on the NMDA receptor complex. These compounds have a pharmacological advantageous profile and may be useful in the treatment or prevention of neuro-degenerative disorders. They are particularly effective in minimizing damage to the central nervous system resulting from ischemic or hypoxic conditions such as stroke, hypoglycemia, cerebral ischemia, cardiac arrest, and physical trauma. Additionally, these compounds may help prevent chronic neurodegenerative disorders, including epilepsy, Alzheimer's disease, Huntington's disease, and Parkinsonism. Their NMDA receptor antagonist properties also suggest potential applications as anticonvulsants, analgesics, antidepressants, anxiolytics, and antischizophrenic agents.
Career Highlights
Jin Il Choi is affiliated with the Korea Research Institute of Chemical Technology, where he continues to advance his research in chemical technology and pharmacology. His work has garnered attention for its potential impact on treating serious neurological conditions.
Collaborations
Jin Il Choi collaborates with esteemed colleagues, including No Sang Park and Churl Min Seong, who contribute to his research endeavors. Their combined expertise enhances the innovative potential of their projects.
Conclusion
Jin Il Choi's contributions to neuropharmacology through his patented inventions highlight the importance of innovation in addressing neuro-degenerative disorders. His work exemplifies the intersection of research and practical application in the medical field.